E. Lukkari

A randomized controlled trial comparing the efficacy of controlled‐release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

Jonathan Birns, E. Lukkari, James Malone‐Lee · British Journal of Urology · 2000 · 60 citations · Full text

Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients

Carl Gustaf Nilsson, E. Lukkari, Mervi Haarala et al. · Neurourology and Urodynamics · 1997 · 43 citations

Cytochrome P450 Specificity of Metabolism and Interactions of Oxybutynin in Human Liver Microsomes

E. Lukkari, Päivi Taavitsainen, Auni Juhakoskr et al. · Pharmacology & Toxicology · 1998 · 39 citations

Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite

E. Lukkari, A. Juhakoski, Kari Aranko et al. · European Journal of Clinical Pharmacology · 1997 · 21 citations

Health Sciences, Drug Resistance, Medicine +7

Effect of food on the bioavailability of oxybutynin from a controlled release tablet

E. Lukkari, Päivi Castrén‐Kortekangas, A. Juhakoski et al. · European Journal of Clinical Pharmacology · 1996 · 16 citations

Food Chemistry, Physiology, Controlled Release Tablet +2